Australian Technical Advisory Group on Immunisation (ATAGI) advice for immunisation providers regarding the administration of seasonal influenza vaccines in 2017

Australia
NITAGs
6 March 2017

During its 62nd meeting in February 2017, ATAGI endorsed its recommendation for annual influenza vaccination for any person ≥6 months of age who wishes to reduce the likelihood of becoming ill with influenza.

drapeau-australie.jpg

Key points:

  • Annual vaccination is the most important measure to prevent influenza and its complications.
  • Annual influenza vaccination is recommended for any person ≥6 months of age who wishes to reduce the likelihood of becoming ill with influenza.
  • Recent evidence suggests protection against influenza may start to decrease from 3 to 4 months following vaccination and early vaccination needs to be balanced with this. While influenza continues to circulate, it is never too late to vaccinate.
  • Only quadrivalent influenza vaccines (QIV) formulations are available in Australia in 2017. Age restrictions apply according to vaccine brand (refer to Table 1).
  • QIVs are funded on the National Immunisation Program (NIP) in 2017 for the following groups:
    • Aboriginal and/or Torres Strait Islander children aged 6 months to <5 years
    • Aboriginal and/or Torres Strait Islander persons aged ≥15 years
    • All persons aged ≥65 years
    • All persons aged ≥6 months who have certain medical conditions which increase the isk of influenza disease complications; for example, severe asthma, lung or heart disease, low immunity or diabetes (refer to Table 3).
    • Pregnant women (during any stage of pregnancy).
  • Influenza vaccination is also strongly recommended, but not funded, for other groups who are at increased risk of influenza and its complications (refer to Table 3 footnote).
  • Persons with egg allergy, including anaphylaxis, can be safely vaccinated with influenza vaccines. Persons with a history of anaphylaxis to egg can be vaccinated with a full vaccine dose in medical facilities with staff experienced in recognising and treating anaphylaxis.
  • Providers are reminded to report all vaccines given to the Australian Immunisation Register.
Documents to download

Related News & Events

  • Americas
    NITAGs

    The Caribbean Immunization Technical Advisory Group (CiTAG), the first NITAG of its kind

    27.03.2018

    With 22 small countries/territories, the Caribbean faced a great challenge in stablishing NITAGs. Given the history of Caribbean countries working successfully together in health, the Health Ministers took the wise decision in 2017 to establish a sub-regional NITAG. This is an efficient mechanism to provide independent advice on immunization to the Ministers of Health in keeping with the recommendations of the Global Vaccine Action Plan (GVAP) and PAHO’S Regional Immunization Action Plan (RIAP).

    Read more
  • 24 -25
    May
    Angola
    NITAGs

    first NITAG meeting

    Luanda, Angola
  • 20 -21
    June
    United States of America
    NITAGs

    ACIP meeting

    US-CDC
    1600 Clifton Road, Atlanta